SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-022233
Filing Date
2022-06-02
Accepted
2022-06-02 16:05:40
Documents
15
Period of Report
2022-06-01
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hsto-8k_20220601.htm   iXBRL 8-K 53904
2 EX-3.1 hsto-ex31_7.htm EX-3.1 14479
3 EX-99.1 hsto-ex991_8.htm EX-99.1 15966
4 GRAPHIC g3vebetnsfgk000001.jpg GRAPHIC 6540
  Complete submission text file 0001564590-22-022233.txt   237327

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA hsto-20220601.xsd EX-101.SCH 5601
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20220601_lab.xml EX-101.LAB 20069
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20220601_pre.xml EX-101.PRE 11943
9 EXTRACTED XBRL INSTANCE DOCUMENT hsto-8k_20220601_htm.xml XML 3678
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 22990788
SIC: 2834 Pharmaceutical Preparations